Trial Profile
The Effect of Intraoperative Continuous Remifentanil Infusion on Glycemic Response and Variability in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Prospective, Randomized, Open Label Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary) ; Fentanyl
- Indications Anaesthesia; Hyperalgesia; Intraoperative pain; Postoperative pain
- Focus Pharmacodynamics
- 02 Apr 2020 Primary endpoint (Blood Glucose Values (More Than One ) 180 mg%) has not been met.
- 02 Apr 2020 Results published in the British Journal of Anaesthesia
- 11 May 2018 Status changed from active, no longer recruiting to completed.